AUPH

Aurinia Pharmaceuticals Inc

AUPH.US auriniapharma.com + Research + Basket
CIK 0001600620
ISIN CA05156V1022
CUSIP 05156V102
Employees 128
Phone 250 744 2487
Fiscal year end December
IPO Jan 26, 1999
Address #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6
16.75
-0.46 (-2.67%)
USD · NASDAQ
52-week range
12.79
19.25
Trading at 61% of the 52-week range
Market Cap
2.29B
P/E Ratio
7.55
Forward P/E
12.02
Book Value
4.63
Div. Yield
N/A
% Institutions
60.68%
% Insiders
6.79%

1 Year

+40.8%

3 Year

+134.1%

10 Year

+468.0%
Description

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

Actions

Add an action for AUPH.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Kevin C. Tang Chairman & CEO 1967
Mr. Stephen P. Robertson Chief Legal Officer, Corporate Secretary & Chief Compliance Officer 1982
Mr. Peter S. Greenleaf M.B.A. Consultant 1970
Mr. Ryan Cole Chief Operating Officer 1987
Mr. Thomas Wei Chief Scientific Officer 1976
Mr. Stewart M. Kroll Chief Development Officer 1959

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Feb 27, 2026 Kevin Tang N/A Purchase 516.44K $13.99 $7.22M SEC
Aug 05, 2025 Kevin Tang N/A Purchase 200.00K $11.68 $2.34M SEC
Aug 04, 2025 Kevin Tang N/A Purchase 100.00K $11.34 $1.13M SEC
Aug 01, 2025 Kevin Tang N/A Purchase 1.00M $10.12 $10.12M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
TANG CAPITAL MANAGEMENT LLC 13.04M Jun 30, 2026 9.80% $10.05 6.66%
BlackRock Inc 8.19M Jun 30, 2026 6.16% $0.00 4.43%
The Goldman Sachs Group Inc 5.62M Jun 30, 2026 4.22% $0.01 292.00%
NEA Management Company, LLC 3.97M Jun 30, 2026 2.98% $4.24 0.00%
Two Sigma Investments LLC 3.47M Jun 30, 2026 2.61% $0.04 1.13%
Arrowstreet Capital Limited Partnership 3.26M Jun 30, 2026 2.45% $0.02 -0.62%
State Street Corp 2.59M Jun 30, 2026 1.95% $0.00 2.47%
Morgan Stanley - Brokerage Accounts 2.31M Jun 30, 2026 1.73% $0.00 3.39%
Marshall Wace Asset Management Ltd 2.04M Jun 30, 2026 1.54% $0.03 9.04%
Geode Capital Management, LLC 1.70M Jun 30, 2026 1.28% $0.00 10.75%
Renaissance Technologies Corp 1.55M Jun 30, 2026 1.16% $0.04 -6.96%
D. E. Shaw & Co LP 1.41M Jun 30, 2026 1.06% $0.01 -10.46%
Vanguard Portfolio Management, LLC 1.36M Jun 30, 2026 1.02% $0.00 8.17%
Jacobs Levy Equity Management, Inc. 1.23M Jun 30, 2026 0.93% $0.08 12.24%
Jupiter Asset Management Limited 1.09M Jun 30, 2026 0.82% $0.09 36.23%
LSV Asset Management 1.08M Jun 30, 2026 0.81% $0.03 3.84%
Nomura Holdings Inc 978.60K Jun 30, 2026 0.74% $0.02 1.00%
AQR Capital Management LLC 948.75K Jun 30, 2026 0.71% $0.01 -0.01%
Northern Trust Corp 863.57K Jun 30, 2026 0.65% $0.00 4.79%
Allianz Asset Management AG 841.73K Jun 30, 2026 0.63% $0.01 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Russell 2000 ETF 3.09M 2.32% ▼ 1.14% Sep 30, 2026
2 GS Glb Sm Cp CORE Eq Base Inc USD Snap 1.51M 1.13% ▲ 65.82% Jul 31, 2026
3 Fidelity Small Cap Index 1.30M 0.98% ▲ 0.91% Jul 31, 2026
4 iShares Russell 2000 Growth ETF 1.12M 0.84% ▼ 0.13% Sep 30, 2026
5 iShares Biotechnology ETF 917.68K 0.69% ▼ 0.75% Sep 30, 2026
6 Vanguard Russell 2000 ETF 693.44K 0.52% ▲ 1.16% Sep 30, 2026
7 Goldman Sachs US Tax-Managed Eq Instl 541.44K 0.41% ▲ 0.00% Jun 30, 2026
8 Nuveen Quant Small Cap Equity R6 480.65K 0.36% ▲ 0.00% Aug 31, 2026
9 Fidelity Enhanced Small Cap Core ETF 456.49K 0.34% ▲ 0.21% Sep 30, 2026
10 Jupiter Merian Glb Eq Abs Rt I USD Acc 399.80K 0.30% ▲ 23.86% Jun 30, 2026

Financial Highlights

▼
Market Cap: $2.29B
EBITDA: $179.83M
P/E Ratio: $7.55
PEG Ratio: $0.00
Book Value: $4.63
Earnings/Share: $2.28
Profit Margin: 100.84%
Operating Margin: 55.69%
ROA (TTM): 15.49%
ROE (TTM): 66.12%
Revenue (TTM): $311.51M
Revenue/Share (TTM): $2.37
Earnings Growth (YOY): 75.50%
Revenue Growth (YOY): 18.90%

Valuation Metrics

Enterprise Value: $1.91B
Trailing P/E: 7.55
Forward P/E: 12.02

Shares Statistics

Shares Outstanding: 133.05M
Shares Float: 129.22M
% Insiders: 6.79%
% Institutions: 60.68%
Shares Short: 7.78M
Shares Short (Prior Month): 7.92M
Short Ratio: 8.95
Short % Float: 6.46%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$283.06M
Cost of Goods Sold
adjust
$-32.67M
Gross Profit
subtotal
$250.39M
SG&A
adjust
$-98.59M
R&D
adjust
$-32.51M
Other Operating Expense
adjust
$-14.39M
Operating Income
subtotal
$104.91M
Other / Non-Operating Items
adjust
$182.29M
Net Income
subtotal
$287.20M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about AUPH.US!